The estimated Net Worth of Terry Nida is at least $30.8 mil dollars as of 31 October 2005. Terry Nida owns over 46,875 units of VIVUS stock worth over $30,781 and over the last 21 years Terry sold VVUS stock worth over $0.
Terry has made over 3 trades of the VIVUS stock since 2004, according to the Form 4 filled with the SEC. Most recently Terry exercised 46,875 units of VVUS stock worth $137,813 on 31 October 2005.
The largest trade Terry's ever made was exercising 46,875 units of VIVUS stock on 31 October 2005 worth over $137,813. On average, Terry trades about 5,133 units every 36 days since 2004. As of 31 October 2005 Terry still owns at least 65,982 units of VIVUS stock.
You can see the complete history of Terry Nida stock trades at the bottom of the page.
Terry's mailing address filed with the SEC is , , , , .
Over the last 21 years, insiders at VIVUS have traded over $6,261,269 worth of VIVUS stock and bought 5,180,746 units worth $13,074,554 . The most active insiders traders include Tide Capital, Llc North Tid..., Alexander J Denner, eErnest Mario. On average, VIVUS executives and independent directors trade stock every 39 days with the average trade being worth of $35,394. The most recent stock trade was executed by John P. Amos on 1 March 2019, trading 11,000 units of VVUS stock currently worth $53,350.
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.
VIVUS executives and other stock owners filed with the SEC include: